Healthcare resource utilization in patients treated with empagliflozin in East Asia

AIMS/INTRODUCTION: We investigated the utilization of healthcare resources in patients with type 2 diabetes treated with empagliflozin, a sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor, versus dipeptidyl peptidase‐4 (DPP‐4) inhibitors in clinical practice in Japan, South Korea, and Taiwan. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheu, Wayne H‐H, Seino, Yutaka, Tan, Elise Chia‐Hui, Yabe, Daisuke, Ha, Kyoung Hwa, Nangaku, Masaomi, Chung, Wook‐Jin, Node, Koichi, Yasui, Atsutaka, Lei, Wei‐Yu, Lee, Sunwoo, Ustyugova, Anastasia, Klement, Riho, Deruaz‐Luyet, Anouk, Kyaw, Moe H, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077718/
https://www.ncbi.nlm.nih.gov/pubmed/34859609
http://dx.doi.org/10.1111/jdi.13728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077718/
https://www.ncbi.nlm.nih.gov/pubmed/34859609
http://dx.doi.org/10.1111/jdi.13728

Ejemplares similares